Company: SXTPW
Filing Date: 2025-02-14
Form Type: S-1
Source: 0001213900-25-014334
Chunk: 45

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-02-14
Form: S-1
Chunk 45
---
 completed fiscal year of more than $100 million and a public common equity float or public float of more than $700 million. We also would not be eligible for status as a smaller reporting company if we become an investment company, an asset-backed issuer or a majority-owned subsidiary of a parent company that is not a smaller reporting company. We have elected to take advantage of certain of the reduced disclosure obligations in the registration statement of which this prospectus is a part and may elect to take advantage of other reduced reporting requirements in future filings. As a result, the information that we provide to our stockholders may be different from what you might receive from other public reporting companies in which you hold equity interests.

24

SUMMARY OF THE OFFERING

| Shares of Common Stock Offered by the Selling Stockholders |     | 3,735,977 shares of common stock consisting of: (i) 2,043,098 shares of our common stock issuable upon exercise of the January 2025 Common Warrants; (ii) 1,503,500 shares of our common stock issuable upon exercise of the February 2025 Common Warrants; (iii) 76,616 shares of our common stock issuable upon exercise of warrants; and (iv) 112,763 shares of our common stock issuable upon exercise of the February 2025 Placement Agent Warrants.                                                                                                                         
 The January 2025 Common Warrants and the February 2025 Common Warrants have an exercise price of $0.771 per share and $0.59 per share, respectively, and are immediately exercisable upon the issuance date and will expire twenty-four months from issuance date. The January 2025 Placement Agent Warrants and the February 2025 Placement Agent Warrants have an exercise price of $1.2763 per share and $0.8938 per share, respectively, and are immediately exercisable upon the issuance date and will expire twenty-four months from issuance date.                        |
| Selling Stockholders                                       |     | All of the shares of common stock being registered pursuant to the registration statement of which this prospectus forms a part are being offered by the Selling Stockholders. See “Selling Stockholders” for more information on the Selling Stockholders.                                                                                                                                                                                                                                                                                                                       |
| Common Stock Outstanding Prior to Offering(1)(2)           |     | 7,364,554 shares of common stock                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Common Stock Outstanding After Offering(1)(2)              |     | 11,100